Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USP Formulary Guide Needs Overhaul To Meet Access Goal, PhRMA, BIO Say

Executive Summary

The U.S. Pharmacopeia should completely overhaul its draft model formulary guidelines for Medicare Part D in order to fulfill its task of creating guidelines that prevent health plans from discriminating against certain Medicare beneficiaries, PhRMA and BIO said

You may also be interested in...



Medicare Rx Coverage Requirements Could Lower Patient Safety, Blues Say

Requiring Medicare drug plans to cover a certain number of drugs could negatively affect patient safety, Excellus BlueCross BlueShield (New York) Chief Pharmacy Officer Joel Owerbach said

Medicare Rx Coverage Requirements Could Lower Patient Safety, Blues Say

Requiring Medicare drug plans to cover a certain number of drugs could negatively affect patient safety, Excellus BlueCross BlueShield (New York) Chief Pharmacy Officer Joel Owerbach said

Rx Discounts Do Not Require Restrictive Formularies, PhRMA Tells USP

Medicare prescription drug plan sponsors will be able to negotiate significant discounts even under a model drug classification system that includes a large number of categories and classes, the Pharmaceutical Research & Manufacturers of America said

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel